home / stock / ptgef / ptgef quote
Last: | $37.50 |
---|---|
Change Percent: | 6.99% |
Open: | $35.9885 |
Close: | $37.50 |
High: | $37.5 |
Low: | $35 |
Volume: | 6,306 |
Last Trade Date Time: | 02/24/2021 04:54:48 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$37.5 | $35.9885 | $37.5 | $37.5 | $35 | 6,306 | 02-24-2021 |
$35.05 | $39.73 | $35.05 | $39.8415 | $35.05 | 12,200 | 02-23-2021 |
$39.5 | $39.5 | $39.5 | $39.9 | $38.7 | 11,921 | 02-22-2021 |
$37.47 | $39.5 | $37.47 | $39.5015 | $34.952 | 17,659 | 02-19-2021 |
$38 | $35.508 | $38 | $41.41 | $34.9985 | 21,006 | 02-18-2021 |
$35 | $30.998 | $35 | $39 | $30.998 | 22,864 | 02-17-2021 |
$30.755 | $24.5 | $30.755 | $31.006 | $24.5 | 17,209 | 02-16-2021 |
$25 | $24.512 | $25 | $25 | $24.5 | 6,648 | 02-15-2021 |
$25 | $24.512 | $25 | $25 | $24.5 | 6,648 | 02-12-2021 |
$24 | $21.596 | $24 | $24.0015 | $19.795 | 20,251 | 02-11-2021 |
$18.55 | $20.02 | $18.55 | $21 | $18.456 | 3,378 | 02-10-2021 |
$21.11 | $21.0015 | $21.11 | $22.22 | $13.84 | 6,754 | 02-09-2021 |
$21.9985 | $21.5 | $21.9985 | $22.16 | $21.01 | 3,147 | 02-08-2021 |
$22.2 | $23 | $22.2 | $23 | $21.5 | 1,766 | 02-05-2021 |
$22.325 | $21.5 | $22.325 | $22.325 | $21.01 | 1,237 | 02-04-2021 |
$21.09 | $22.75 | $21.09 | $22.75 | $21.09 | 780 | 02-03-2021 |
$22.5 | $22 | $22.5 | $22.56 | $22 | 1,984 | 02-02-2021 |
$22.0085 | $21.01 | $22.0085 | $22.0085 | $21.01 | 632 | 02-01-2021 |
$22.49 | $22 | $22.49 | $23 | $21.0015 | 1,092 | 01-29-2021 |
$23.05 | $23 | $23.05 | $23.9985 | $20.75 | 10,297 | 01-28-2021 |
News, Short Squeeze, Breakout and More Instantly...
Portage Biotech Company Name:
PTGEF Stock Symbol:
OTCMKTS Market:
-- Company to advance three clinical-stage programs in pipeline -- -- Portage has received approval and is preparing for NASDAQ listing -- Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") today annou...
New York, New York--(Newsfile Corp. - December 1, 2020) - Portage Biotech (OTC Pink: PTGEF) (CSE: PBT.U) is an emerging biotechnology company developing an immunotherapy focused pipeline to treat a broad range of cancers. Unlike most biotechs though, Portage focuses on combining its own techno...
Toronto, Ontario--(Newsfile Corp. - October 16, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that the Company has filed its interim financial statements and related management's discussion and analysis for the three-month period ending June...